<DOC>
	<DOCNO>NCT00262249</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . The purpose trial compare effect NorditropinÂ® use different dose regimen child suspect growth hormone deficiency .</brief_summary>
	<brief_title>Effect Growth Hormone Children With Growth Hormone Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Dwarfism</mesh_term>
	<mesh_term>Growth Disorders</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Clinically suspect GHD Height &lt; 2.0 SDS Serum IGFI less equal 1.0 SDS Bone age less equal 9 year boys less equal 7 year girls . Puberty Tanner Stage I Previous use growth hormone Growth retardation attributable cause GHD ( e.g . inborn error metabolism , primary bone disease , chromosomal disorder , etc . ) Intrauterine growth retardation : birth weight &lt; 3rd percentile . Administration growthaltering medication . Evidence malignancy intracranial tumor .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>